Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthase
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthase
Authors
Keywords
-
Journal
Nature Chemical Biology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-12-03
DOI
10.1038/s41589-021-00900-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors
- (2021) Courtney L. Jones et al. Cell Stem Cell
- Labeling Preferences of Diazirines with Protein Biomolecules
- (2021) Alexander V. West et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth
- (2021) Denise Sighel et al. Cell Reports
- Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Acute Myeloid Leukemia Patients
- (2020) Shanshan Pei et al. Cancer Discovery
- Metabolic reprogramming and cancer progression
- (2020) Brandon Faubert et al. SCIENCE
- Mitochondrial ubiquinol oxidation is necessary for tumour growth
- (2020) Inmaculada Martínez-Reyes et al. NATURE
- Synthesis and Multiplexed Activity Profiling of Synthetic Acylphloroglucinol Scaffolds
- (2020) John Porco et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?
- (2020) Yibin Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting mitochondrial respiration for the treatment of acute myeloid leukemia
- (2020) Jenna L. Carter et al. BIOCHEMICAL PHARMACOLOGY
- Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction
- (2020) Ali Punjani et al. NATURE METHODS
- Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
- (2019) Irène Baccelli et al. CANCER CELL
- User-defined single pot mutagenesis using unamplified oligo pools
- (2019) Angélica V Medina-Cucurella et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies
- (2019) Romain Guièze et al. CANCER CELL
- Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response
- (2019) David Sharon et al. Science Translational Medicine
- Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
- (2018) Thomas M. Ashton et al. CLINICAL CANCER RESEARCH
- An inhibitor of oxidative phosphorylation exploits cancer vulnerability
- (2018) Jennifer R. Molina et al. NATURE MEDICINE
- Cryo-EM of ATP synthases
- (2018) Hui Guo et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- A Novel MCL-1 Inhibitor Combined with Venetoclax Rescues Venetoclax Resistant Acute Myelogenous Leukemia
- (2018) Haley E. Ramsey et al. Cancer Discovery
- Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
- (2018) Courtney L. Jones et al. CANCER CELL
- Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
- (2018) Daniel A. Pollyea et al. NATURE MEDICINE
- MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
- (2017) Shawn Q Zheng et al. NATURE METHODS
- cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
- (2017) Ali Punjani et al. NATURE METHODS
- Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
- (2017) Thomas Farge et al. Cancer Discovery
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Modeling congenital disease and inborn errors of development inDrosophila melanogaster
- (2016) Matthew J. Moulton et al. Disease Models & Mechanisms
- Plasmid-based one-pot saturation mutagenesis
- (2016) Emily E Wrenbeck et al. NATURE METHODS
- Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from oligomycin A
- (2015) Jeffrey D. Serrill et al. BIOCHEMICAL PHARMACOLOGY
- AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress
- (2015) S. Sriskanthadevan et al. BLOOD
- The promise and peril of chemical probes
- (2015) Cheryl H Arrowsmith et al. Nature Chemical Biology
- Fluorescent Probes of the Apoptolidins and their Utility in Cellular Localization Studies
- (2014) Sean M. DeGuire et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
- (2013) Eleni D. Lagadinou et al. Cell Stem Cell
- Fabrication of carbon films with ∼500nm holes for cryo-EM with a direct detector device
- (2013) Chelsea R. Marr et al. JOURNAL OF STRUCTURAL BIOLOGY
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
- (2013) F. Wang et al. SCIENCE
- Imaging energy status in live cells with a fluorescent biosensor of the intracellular ATP-to-ADP ratio
- (2013) Mathew Tantama et al. Nature Communications
- Oligomycin frames a common drug-binding site in the ATP synthase
- (2012) J. Symersky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Biosynthesis of the apoptolidins in Nocardiopsis sp. FU 40
- (2011) Yu Du et al. TETRAHEDRON
- An Improved Cryogen for Plunge Freezing
- (2008) William F. Tivol et al. MICROSCOPY AND MICROANALYSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More